Background: When using administrative databases for epidemiologic research, a subsample of subjects can be interviewed, eliciting information on undocumented confounders. this article presents a thorough investigation of the validity of a two-stage sample encompassing an assessment of nonparticipation and quantification of the extent of bias. Methods: established through record linkage of administrative databases, the Québec Birth cohort on immunity and Health (n = 81,496) aims to study the association between Bacillus calmette-guérin vaccination and asthma. among 76,623 subjects classified in four Bacillus calmette-guérin-asthma strata, a two-stage sampling strategy with a balanced design was used to randomly select individuals for interviews. We compared stratum-specific sociodemographic characteristics and healthcare utilization of stage 2 participants (n = 1,643) with those of eligible nonparticipants (n = 74,980) and nonrespondents (n = 3,157). We used logistic regression to determine whether participation varied across strata according to these characteristics. the effect of nonparticipation was described by the relative odds ratio (rOr = Or participants /Or source population ) for the association between sociodemographic characteristics and asthma. Results: Parental age at childbirth, area of residence, family income, and healthcare utilization were comparable between groups. Participants were slightly more likely to be women and have a mother born in Québec. Participation did not vary across strata by sex, parental birthplace, or material and social deprivation. estimates were not biased by nonparticipation; most rOrs were below one and bias never exceeded 20%. Conclusions: Our analyses evaluate and provide a detailed demonstration of the validity of a two-stage sample for researchers assembling similar research infrastructures.
P opulation-based epidemiologic studies relying on administrative data have become common in recent years. to address an intrinsic limitation to the use of administrative databases for epidemiologic research-the lack of pertinent information on some potential confounders of a given exposure-outcome association-covariate information can be collected from a subset (stage 2) of the initial study population (stage 1). the two-stage sampling design, important issues in sample selection, correcting for sampling fractions, and efficiency of this design compared with random and disease-or exposure-based sampling are well described elsewhere. [1] [2] [3] [4] [5] [6] as in any epidemiologic study, selection bias could hamper validity. that is, if participation were related to both the exposure and disease of interest, the resulting estimates of exposure-disease association would generally be biased. Detailed information that would allow for the comparison between characteristics of participants and nonparticipants is rarely available except in such a two-stage sampling approach, which provides a suitable framework for assessing the potential presence and effect of selection bias.
Only a few studies based on a two-stage sampling design compared characteristics of participants with those of nonparticipants. 7, 8 those were presented as part of the overall analysis of exposure-disease associations, without an indepth evaluation of potential selection bias. to the best of our knowledge, only Hoggatt and collaborators have specifically addressed adjustment for response bias in the context of a two-phase analysis, focusing principally on a comparison of analytical methods. 9 in this study, we present a thorough investigation of the validity of a two-stage sample, including an assessment of nonparticipation and quantification copyright of the extent of bias. We specifically assessed (1) stratumspecific representativeness of stage 2 participants, (2) participation rates according to sociodemographic characteristics and healthcare utilization across strata, and (3) the extent of bias observed when analyzing the association between sociodemographic characteristics and asthma among stage 2 participants as compared with stage 1 subjects.
METHODS

Cohort Establishment
recently, the Québec Birth cohort on immunity and Health (QBciH) was set up to assess, at the population level, the relationship between nonspecific immune stimulation at an early age, as resulting from Bacillus calmette-guérin (Bcg) vaccination, 10 and childhood asthma occurrence, using provincial demographic and health administrative databases. the QBciH was assembled through the linkage of several provincial administrative demographic and medical databases. these included the (1) Birth registry from the Ministry of Health and Social Services, handled by Statistics Québec (Institut de la statistique du Québec); (2) 2010 Healthcare registration File from the Québec Health insurance (Régie de l'assurance maladie du Québec, raMQ); and (3) Québec Bcg Vaccination registry. Probabilistic record linkage between these databases was carried out by analysts at Statistics Québec using five basic nominal identifiers (child's surname and given name, date of birth, sex, father's given name). 11 linkage was performed using the "generalized record linkage System" software developed by Statistics canada. 12 Before establishing the current cohort, linkage of the Québec Bcg Vaccination registry to the same administrative databases was examined and proved to be highly feasible, with the highest linkage rate (87%) achieved for the 1974 birth year using a probabilistic approach. 13 the QBciH retrospective birth cohort includes 81,496 subjects, representing 90% of eligible subjects: all children born at or after 32 weeks of gestation in the province of Québec, canada in 1974 ( Figure 1 ). the exclusion of very premature babies born at less than 32 weeks of gestation was based on the high mortality rate and numerous health complications in this subgroup, including respiratory. 14, 15 
Description of Variables Retrieved from the Administrative Databases
Bcg-vaccinated subjects were identified using the Québec Bcg Vaccination registry database, recently demonstrated to be highly complete and accurate. 13 linkage with the Birth registry allowed us to obtain individual-level demographic characteristics (sex, date, and place of birth), parental demographic information (age at childbirth, birthplace), and birth-related characteristics (birth weight, gestational age, mother's previous number of live births/stillbirths, total number of deliveries). Using international classification of Diseases codes, data on medical events related to asthma, allergic diseases, and otolaryngology disorders were extracted from their date of first availability to 1994. these included data from the (1) raMQ Medical Services claims database (physician billing) for the time period 1983-1994; and (2) MeD-ÉcHO (Maintenance et Exploitation des Données pour l'Étude de la Clientèle Hospitalière) database for hospitalizations in acute care hospitals between 1987 and 1994. Subjects who had two or more asthma-related medical services or at least one asthma hospitalization were considered asthmatics. the use of asthma definitions based on canadian health administrative data was previously validated. 16, 17 Vital status was determined through the Death registry, from which the date and medical cause of death were obtained. neighborhood-level socioeconomic information was derived from postal sorting areas, defined by the first three digits of subjects' residential postal codes. For the study period , canadian census computerized databases, organized by postal sorting areas, were available for census years 1976, 1981, 1986, 1991, and 1996 . However, postal codes were only available from 1987 in the Healthcare registration File. aggregate measures of family income were assigned to subjects according to the first three digits of their 1991 residential postal codes, obtained from the provincial Healthcare registration File. area of residence was defined as rural or urban based on the subjects' residential postal code in 1991. the second character of the postal code indicates whether mail delivery is considered by canada Post to be rural (denoted by a 0) or urban (denoted by values 1 to 9). 18
Stage 2 Sampling
a two-stage sampling strategy with a balanced design 1,2,5 was used to gather information on potential confounders of the association between Bcg vaccination and asthma, which were not documented in administrative databases. this approach maximized cost efficiency by providing confounder information for a subsample of the initial study population. 2, 19 Subjects were recruited across four strata defined by Bcg vaccination and asthma status, oversampling from the smallest cells of the 2 × 2 table (Bcg vaccinated and nonvaccinated asthmatics), thereby obtaining the best possible precision for adjusted estimates of association. 6 the risk estimate and confidence interval of the Bcg-asthma association would then need to be adjusted for the "selection bias" introduced by oversampling for the smallest cells of the 2 × 2 table (from stage 1 to stage 2) based on the known sampling fractions for each cell of the 2 × 2 table, as described by collet et al. 5 the validity of this approach relies though on stratumspecific representativeness of the stage 2 sample. a total of 4,800 randomly selected subjects, 1,200 per stratum, were sent an introductory letter explaining the study "Survey on childhood environment and the development of allergic diseases," and inviting them to participate ( Figure 2 ). Subsequently, trained interviewers from Statistics Québec contacted potential participants to explain, using a standardized script, the purpose of the study and to describe the interview process. recruitment procedures and questionnaire administration were first pretested using a sample of 128 subjects. accordingly, we refined the interviewers' script and questionnaire structure, and reformulated some questions. interviews were conducted between april 26 and July 7, 2012. after giving verbal consent, participants completed a computer-assisted telephone interview, and answers were entered in real time using the Interviewer software (Voxco, Montreal, Qc). administered in either French or english, the questionnaire incorporated questions based on and adapted from the standardized validated questionnaire of the international Study of asthma and allergy in childhood, 20 other validated questionnaires, 21, 22 in addition to questions developed by Statistics Québec, 23 members of our research team, 24 and other researchers. [25] [26] [27] We collected information on important predictors of asthma development including personal and familial history of asthma and allergic diseases, history of childhood respiratory and other infections, immunizations, presence of regular smokers in the household, pet ownership, parental education, and occupation, as well as urban versus rural living during childhood.
as seen in Figure 2 , for subjects with a valid phone number, participation rates were 58% among Bcg-vaccinated asthmatics, 55% among nonvaccinated asthmatics, 58% among vaccinated nonasthmatics, and 54% among nonvaccinated nonasthmatics. the overall participation rates, calculated by dividing the number of completed interviews by the number of potentially eligible subjects, were 37%, 32%, 37%, and 30% in strata 1 to 4, respectively.
the procedures, data access, and ethical approval for the establishment of the QBciH and stage 2 sample were obtained from the Commission d'accès à l'information (cai) du Québec, inrS research ethics committee, Fonds de recherche du Québec-Santé, raMQ, and Statistics Québec. all members of the research team signed a confidentiality agreement. 
Statistical Analyses
eligible nonparticipants (n = 74,980) included individuals who were not selected to participate in the study (n = 71,823), decliners (n = 1,280), and those selected but not approached (individuals not present in the Healthcare registration File or without valid phone numbers, n = 1,877). the latter two groups of individuals are referred to hereafter as nonrespondents (n = 3,157). the validity of the stage 2 sample was assessed by verifying its representativeness within each stratum of the population from which it was identified and selected. characteristics of stage 2 participants were investigated by making two sets of comparisons within Bcg vaccination and asthma strata: stage 2 participants (n = 1,643) versus eligible nonparticipants (n = 74,980), and stage 2 participants versus nonrespondents (n = 4,800). as appropriate, differences in proportions and means along with their 95% confidence interval (ci) were calculated to contrast, per stratum, sociodemographic characteristics, and healthcare utilization between compared groups. the use of healthcare services included medical visits and hospitalizations related to asthma, allergic diseases, and otolaryngology disorders. Differences between compared groups were considered meaningful if absolute differences in the characteristics were greater than five percentage points.
Participation rates per stratum
characteristics that differed between stage 2 participants and nonrespondents from the previous analysis were used in logistic regression models to determine whether participation in stage 2 (binary dependent variable, yes/no) differed between strata according to these characteristics by testing interaction terms. the characteristics considered were sex, parental birthplace, and the canadian index of material and social deprivation. 28 We estimated odds ratios (Ors) and 95% cis for the associations of individual-and neighborhood-level characteristics with asthma occurrence in stage 1 subjects and stage 2 participants using logistic regression. For the latter group, the model was adjusted for Bcg vaccination to correct for selection bias introduced by our two-stage sampling strategy that used a balanced design according to Bcg vaccination and asthma status. For the association between Bcg vaccination and asthma among stage 2 participants, the Or was further adjusted for sampling fractions. 5 the effect of nonparticipation on the Ors was described by the relative odds ratios (rOrs), 29, 30 calculated as Or stage 2 participants /Or stage 1 subjects , and corresponding 95% cis. the rOr is equal to one if no bias is present. Because estimates based on the two groups (total sample and subsample) are inherently positively correlated, standard methods for obtaining standard errors of the difference do not apply. as proposed by nohr and colleagues, 30 cis for the rOrs were derived using the following equation: Se(rOr) = square root of [Se(Or stage 2 participants ) 2 − Se(Or stage 1 subjects ) 2 ]. all analyses were conducted using SaS enterprise guide, version 4.2 (SaS institute inc., cary, nc). table 1 shows the comparison between stage 2 participants and eligible nonparticipants with respect to sociodemographic characteristics. the two groups were similar in all strata regarding the number of older siblings, parental age at childbirth, area of residence, and family income. the distribution differed between the two groups for a few characteristics. Within each stratum, women were over represented in participants as compared with eligible nonparticipants; the proportion of women was higher by 7% to 9%. For maternal birthplace, an absolute difference of >5 percentage points was only found for non-Bcg-vaccinated asthmatics; in this stratum, the proportion of mothers born in Québec was 6% higher in participants than in eligible nonparticipants. With regards to healthcare utilization, table 2 shows only small differences between participants and eligible nonparticipants in terms of medical visits and hospitalizations related to asthma, allergic diseases, and otolaryngology disorders in stratum-specific comparisons.
RESULTS
compared with the 3,157 nonrespondents, participants did not differ on the language of correspondence (French or english), area of residence, and healthcare services use for asthma, allergic diseases, and otolaryngology disorders, for all strata (etable 1; http://links.lww.com/eDe/a980). generally, a lower response rate was found among men, among the most deprived, and among subjects whose parents were born outside Québec (etable 1; http://links.lww.com/eDe/a980); absolute differences in these characteristics varied from 5% to 9%. Yet, differences between participants and nonrespondents did not vary across strata. in logistic regression models relating sex, parental birthplace as well as the material and social deprivation index to participation (dependent binary variable, yes/no), all tests of interaction between these characteristics and the strata yielded P values >0.28 (table 3) . table 4 shows the extent of participation bias affecting the study by comparing estimates of association between sociodemographic characteristics and asthma, derived from stage 1 subjects and stage 2 participants. these estimates of association, obtained using a single model that included all variables, changed little from a series of univariate models (data not shown). as shown, the Ors for asthma from both groups were generally similar, except for slightly stronger associations among stage 2 participants for the number of older siblings (in one category: one older sibling), and family income (in two categories: second and third quartiles). the rOrs varied from 0.88 (12% underestimate of stage 1 Or) to 1.2 (20% overestimate of stage 1 Or), but most were below one and none were different from one when considering the cis. adjusting for all sociodemographic factors from the stage 1 sample presented in table 4, the Ors for Bcg vaccination and asthma were 0.89 (95% ci = 0.84, 0.94) in stage 1 subjects, and 0.90 (95% ci = 0.80, 1.0) in stage 2 subjects after adjusting for sampling fractions. the rOr for the Bcg-asthma association was 1.0 (95% ci = 0.82, 1.3).
DISCUSSION
Our study is one of few studies to present a systematic approach to investigating the validity of a two-stage sample when using administrative databases for epidemiologic research. Overall, there was no marked indication of a lack of stratum-specific representativeness of stage 2 participants in terms of sociodemographic characteristics and healthcare utilization, either relative to the study population from which they were identified and recruited or when compared with nonrespondents. nonetheless, although rOrs for sociodemographic factors and Bcg vaccination were near unity, cis for the point estimates suggest moderate-sized associations in either direction, compatible with a certain degree of positive or negative nonparticipation bias. (5) 86 (4) 35 (8) 1,947 (6) 19 (5) 144 (5) 25 (7) 2,496 (7) % Difference (95% ci) a 0. (3) 102 (5) 13 (3) 1,544 (5) 51 (14) 519 (19) 68 ( 580 (28) 173 (40) 12,100 (38) 66 (17) 516 (18) 77 (22) 8,432 (24) Urban the observed differences on a few demographic characteristics such as maternal birthplace were rather small. the low prevalence of women born outside Québec makes maternal birthplace an unlikely confounder. even though women are generally known to be more likely to participate in studies than men, 5 differential participation of women according to exposure and disease status could introduce bias. Since the degree of nonrepresentativeness by sex did not vary across strata defined by Bcg vaccination and asthma status, selective nonparticipation according to sex would not lead to biased inferences.
the consequence of selection bias is that the association between exposure and outcome among subjects selected for analysis would differ from that among those eligible. 31, 32 in agreement with previous studies assessing the extent of selection bias by comparing exposure-outcome association estimates derived from two study groups (sample and original study population) based on the rOrs, 29, 30, 33 our responserelated bias analyses suggest that participation was mostly nondifferential; only small effects were observed on the rOrs with the largest bias found in relation to the number of older siblings. in previous studies, similarly small deviations in the Ors were observed regardless of a high (82%) 29 or a low (30%) participation rate. 30 Hoggatt and collaborators 9 have presented an approach for verifying the presence of response bias and showed an application of two-stage analytical methods to account for it. Missing data techniques can also be used. 34, 35 One simple approach is to consider subjects in stage 2 as having complete data and those who are only present in stage 1 would represent subjects with missing data on covariates collected in stage 2. 36 the modest participation rates obtained in this study would not necessarily result in biased exposure-outcome estimates. 30, 37 However, bias due to selective nonparticipation is more likely than not in such a situation. We opted to report several participation rates carefully explaining how they were calculated, along with a detailed presentation of the enrollment process and the number of participants in each step and across strata, as previously advocated. 37 even if permitted by the provincial body that regulates access to confidential information, we were not granted access to subjects' telephone numbers by the healthcare provider (raMQ), which influenced the overall participation rate. through automated and manual searches, a valid telephone number was retrieved for 70% of subjects in each stratum among whom the participation rate was 56% (1,643/2,923) . reasons for nonparticipation included refusal of contacted subject, but also inability to reach the person despite several attempts and prolonged absence of the invited participant.
it has been suggested that individuals who are not approached to participate in research studies may be more different from participants than those who are approached but declined. 38 We could not differentiate between the various categories of nonparticipants due to subjects' confidentiality restrictions applied by Statistics Québec. the interviews being conducted by Statistics Québec team, we were only provided information on those who agreed to participate, and descriptive statistics on those who refused. thus, the subgroup of subjects who were not approached to participate in the study could not be separately compared with stage 2 participants. Few studies have considered the composition of nonresponse in various categories of nonparticipants. 38, 39 Demographic and clinical differences have been found between participants and nonparticipants (those who declined or were not approached), 38 which might have been related to a variety of issues (i.e., study design, invasiveness of study procedures, understanding the importance of research) in an HiV cohort study. conversely, small differences have been observed between participants and nonrespondents (refusals; ill, disabled or in hospital; not approached) based on analyses of trends in nonresponse and the composition of nonrespondents in the 1987, 1991, and 1994 Danish Health interview Surveys. 39 Our study presented some limitations that are worth mentioning. When analyzing participation rates according to sociodemographic characteristics (as presented in table 3), we could not do so with a multivariate approach as we were not given access to the specific dataset that would enable such an analysis. Our work on administrative databases was heavily governed by data privacy and ethical considerations. as such, we were not allowed to know which subjects were approached for participation by Statistics Québec and refused. the lack of difference in participation by strata for the variables separately considered does not necessarily imply absence of appreciable bias in subgroups defined by cross-classification of covariates. all variables were mutually adjusted for one another. a total of 8,977 and 173 observations were deleted from the calculation of Or 1 and Or 2 , respectively, due to missing values. a Further adjusted for Bcg vaccination status to correct for selection bias inherent to the two-stage sampling strategy using a balanced design according to Bcg vaccination and asthma status. b Defined as the ratio of the Or among stage 2 participants (Or 2 ) to the corresponding Or in stage 1 subjects (Or 1 ). c Determined using the second character of subjects' residential postal codes (0: rural, ≠0: urban). d Quartiles based on the distribution of the continuous family income variable among all subjects in the birth cohort (n = 81,496).
nonetheless, the rOrs presented in table 4 comparing associations between sociodemographic factors and asthma among stage 1 and stage 2 participants were obtained from multivariate models. Our study was also limited to comparisons of variables available for both stage 1 and stage 2 samples. the possibility of nonparticipation bias in the analysis of the main exposure of interest remains if nonparticipation were to vary with factors measured only in the second stage or unmeasured. With respect to factors assessed in this study, we have previously published on the determinants of Bcg vaccination in this study population. 40 Mother's education and grandparents' ethnocultural origin, measured in the second stage, were related to Bcg vaccination. However, when considering covariates from both stages 1 and 2, only parental birthplace and residential area (urban/rural residence), available in stage 1, remained as predictors of Bcg vaccination. Strengths of this study include the large population-based sample as well as the comparison of various administratively based sociodemographic and healthcare utilization data available for the source population (1974 birth cohort). Besides relying on the use of medical administrative data, our study had the distinguishing advantage of acquiring information from the Birth registry. We contribute to the existing literature by presenting a systematic approach for assessing the validity of a subsample within the context of a two-stage sampling strategy with a balanced design. the balanced design has been recognized as being the most efficient approach, 5 but due to the high prevalence of Bcg vaccination (46%, 35,612/76,623 subjects) in the birth cohort, the creation of four strata defined by Bcg vaccination and asthma status rather than two (asthmatics vs. nonasthmatics) could have brought marginal benefits.
in summary, although participation rates among subjects with valid telephone numbers in the stage 2 sample ranged between 54% and 58% per stratum, our findings generally indicate slight differences between stage 2 participants and the source population along several demographic, geographic, socioeconomic, and health aspects. the effect of nonparticipation on associations of sociodemographic factors and Bcg vaccination with asthma occurrence was small. Our results support the validity of the stage 2 sample within the QBciH. nowadays, epidemiologic studies require large sample sizes to assess modest exposure-outcome associations, and the cost of conducting large studies based on individual interviews is prohibitive. With greater use of administrative databases for research purposes, the present documentation and assessment of the validity of a two-stage sample will become increasingly useful.
